Results

Total Results: 579 records

Showing results for "Grade D Cancer".

41. Colorectal-Cancer-Protocol_130520 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - Disease characteristics (e.g., tumor grade) iii. … Disease characteristics (e.g., tumor grade) iii. … Although we have grouped all colon and rectal cancers together as “colorectal cancer” as an inclusion … D IVB Any T Any N M1b D D AJCC: American Joint Committee on Cancer MAC: Modified Astler-Coller system … exp Colorectal Neoplasms/ or exp colon cancer/ or exp colon tumor/ or exp rectum cancer/ or exp rectum

42. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
    September 27, 2012 - die with hepatic metastases.1 Colorectal cancer is the most common malignancy that metastasizes to … d. … "[Mesh] OR ((hepatic OR liver) AND (cancer OR cancers OR oncology OR neoplasms)) AND "Colorectal Neoplasms … OR cancers OR oncology OR neoplasms AND colon OR colorectal OR rectal OR intestinal OR rectum OR intestine … D.

43. Liver-Cancer-Therapy Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
    November 28, 2012 - Disease is staged from 0 to D. … D. … Moher D, Pham B, Lawson ML, et al. … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable

44. Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
    August 01, 2012 - Among women with invasive cancer, rates of MRI use de- creased with higher grade disease. … Use was higher for women with larger or higher grade tumors. … bilateral breast cancers. … In general, women with higher risk DCIS (larger tumor size, higher grade disease, or ER-negative tumors … Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: Cancer J Clin 2012;62(1):10-29. 2.

45. Data Points #14: Use of endocrine therapy following diagnosis of ductal carcinoma in situ or early invasive breast cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dcis-endocrine-therapy/research
    September 13, 2012 - With early invasive disease, use increased with increasing tumor size and declined with higher grade. … Both act by reducing the amount of estrogen that reaches the tumor. … Prior to the passage of the Medicare Part D benefit, the Medicare program provided no coverage for tamoxifen … or AIs; however, both classes of medication are now included in Part D benefits. … it is possible to examine use of these medications among elderly patients enrolled in Medicare Part D.

46. Bladder-Cancer-Muscle-Invasive Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
    July 21, 2014 - Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors.6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … D. … Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30. … and Treatment of Non- metastatic Muscle-invasive Bladder Cancer 1. exp Urinary Bladder Neoplasms/

47. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
    December 08, 2014 - Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … Tumor response d. Harms due to overtreatment or undertreatment e. Survival f. … d. … Testing for recurrent small cell lung cancer will be excluded. d. … '/de OR cancer OR tumor* OR tumour* OR mass* OR neoplasm* AND (stage OR 'staging'/de OR staging OR class

48. Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-ovarian-contraceptives/research-protocol
    February 15, 2012 - step in the development of all tumors. … D. … of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer … Beral V, Bull D, Green J, et al. … Moher D, Liberati A, Tetzlaff J, et al.

49. Treatment of Non-metastatic Muscle-invasive Bladder Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
    July 21, 2014 - Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors. 6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … D. … References Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. … and Treatment of Non-metastatic Muscle-invasive Bladder Cancer exp Urinary Bladder Neoplasms/ (42649

50. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
    January 01, 2023 - There were significantly fewer acute AEs and late AEs Grade ≥2 with IORT. … Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers … Wallner P, Arthur D, Bartelink H, et al. … Smith TE, Lee D, Turner BC, et al. … Moher D, Liberati A, Tetzlaff J, et al.

51. Head-Neck-Cancer-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
    December 01, 2014 - carcinoma of the head and neck (SCCHN) constitutes approximately 90 percent of all head and neck cancers … The overall strength of evidence (SOE) grade is classified into four categories, as shown in Table A … Gupta et al. reported aggregated survival results in patients with tumors in different sites. … Intensity-modulated radiation therapy in head and neck cancers: an update. … Head and neck cancers. J Nat Compr Cancer Netw. 2011 Jun 1;9(6):596-650. PMID: 21636536. 9.

52. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
    February 22, 2012 - recurrence, noncancer-related mortality, and second malignancies.2, 3 Malignant Endobronchial Obstruction … D. … Owens DK, Lohr KN, Atkins D, et al. … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non- small-cell' OR 'non-small cell' OR 'non … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non- small-cell' OR 'non-small cell' OR 'non

53. Standardized Library of Lung Cancer Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lung-cancer.pdf
    August 01, 2021 - Regarding toxicity, over 750 Grade 3 or Grade 4 complications are listed in CTCAE v5 for radiation therapy … Rather than model each complication, observations were created for “CTCAE grade 3” and “CTCAE grade … This approach also allows the definition to capture Grade 3 or Grade 4 complications, regardless of … RECIST (Response Evaluation and Criteria in Solid Tumors) Guideline1 definition of Progressive Disease … change in lesion, must be captured. 1 Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D,

54. Standardized Library of Lung Cancer Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lung-cancer.pdf
    August 01, 2021 - Regarding toxicity, over 750 Grade 3 or Grade 4 complications are listed in CTCAE v5 for radiation therapy … Rather than model each complication, observations were created for “CTCAE grade 3” and “CTCAE grade … This approach also allows the definition to capture Grade 3 or Grade 4 complications, regardless of … RECIST (Response Evaluation and Criteria in Solid Tumors) Guideline1 definition of Progressive Disease … change in lesion, must be captured. 1 Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D,

55. Colorectal-Cancer-Liver-Metastases-Therapies Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
    December 01, 2012 - Most colorectal cancers are adenocarcinomas, meaning that they are a cancer of the epithelium originating … Is extended hepatectomy for hepatobiliary malignancy justified? … Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal … HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. … Recommendations for radioembolization of hepatic malignancies using Yttrium-90 microsphere brachytherapy

56. Standardized Library of Lung Cancer Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/white-paper-lung-cancer_0.pdf
    August 01, 2021 - Regarding toxicity, over 750 Grade 3 or Grade 4 complications are listed in CTCAE v5 for radiation therapy … Rather than model each complication, observations were created for “CTCAE grade 3” and “CTCAE grade … This approach also allows the definition to capture Grade 3 or Grade 4 complications, regardless of … RECIST (Response Evaluation and Criteria in Solid Tumors) Guideline1 definition of Progressive Disease … change in lesion, must be captured. 1 Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D,

57. skin-cancer-protocol-160810 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
    August 10, 2016 - ) and squamous cell carcinoma (SCC), are the most common malignancies in the U.S.1 BCC and SCC are collectively … Bickers DR, Lim HW, Margolis D, et al. … ;O'Connell, D.;Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. … or "Oropharyngeal Neoplasms"[Mesh] OR Pharynx OR Pharyngeal neoplasms OR "Pharyngeal Neoplasms"[Mesh … ] or "Lung Neoplasms"[Mesh] or "Urinary Bladder Neoplasms"[Mesh] or "Uterine Cervical Neoplasms"[Mesh

58. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
    October 27, 2015 - On one end of the spectrum are patients with low grade noninvasive tumors that rarely develop tumors … On the other end are patients with high grade tumors invading the lamina propria with or without coexistant … grade along with We did abstract tumor grade and revised this sentence to be clearer that this was … As noted by the reviewer, accuracy increased with higher tumor stage and grade. … As noted by the reviewer, accuracy increased with higher tumor stage and grade.

59. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
    July 01, 2017 - Renal cell carcinoma accounts for more than 94 percent of kidney malignancies. … † The overall evidence grade was assessed based on the ratings for the following domains: study limitations … d The Clavien-Dindo classification system is used to grade complications from urological surgical interventions … : Dindo D, Demartines N, Clavien PA. … (9,401) A positive relationship between tumor size and malignancy risk was found. 1.326 (1.220 to

60. Bladder-Cancer-Non-Muscle-Invasive Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
    July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … stage, grade, size, or molecular/genetic markers? … Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30. … and Treatment of Non- metastatic Muscle-invasive Bladder Cancer 1. exp Urinary Bladder Neoplasms/